HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Physicians Formula picks Berry

This article was originally published in The Rose Sheet

Executive Summary

Jeff M. Berry will join Physicians Formula's board of directors, effective Oct. 25. Berry currently is VP and treasurer of Del Monte Foods, where he oversees corporate treasury, mergers and acquisitions, business development, financial strategy and public relations. Berry "brings a wealth of public company and long-term planning and strategy experience with branded consumer companies. We look forward to his input as we continue to build upon our distribution platform," CEO Ingrid Jackel says. Berry is replacing James A. Lawrence, who has stepped down from Physicians Formula's board to make time for his duties as new CFO of the Unilever Group, according to Oct. 26 release. Board member Zvi Eiref will take Lawrence's place as chair of the audit committee, the company says...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015062

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel